BLOG

Tuesday, November 24, 2020

As refinancing risks ease, S&P affirms Glenmark Pharma's 'BB-' rating

The rating agency has a stable outlook on Glenmark Pharma's rating and also removed it from 'CreditWatch'

from Companies https://ift.tt/2HzeGGj
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...